ENGNWenGene Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of enGene Therapeutics Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENGNW본 종목 | $15M#6 | 0.1x#1 | 0.1x#1 | — | — | -112.7%#10 | — | -50.9%#1 | — | — | -89.4%#8 | — |
| CVM | $24M#1 | — | 2.2x#4 | 92.6x#4 | 65.5%#1 | 5.6%#4 | -9396.5%#4 | -231.9%#3 | — | — | -78.8%#6 | — |
| BKHA | $20M#2 | — | — | — | — | -30.6%#9 | — | — | — | — | 48.0%#1 | 260.2%#1 |
| SCLX | $16M#3 | — | — | 0.5x#1 | -46.5%#4 | -413.8%#11 | -1143.7%#2 | — | — | 4#1 | -83.6%#7 | — |
| ABOS | $15M#4 | — | 0.4x#2 | — | — | -18.6%#7 | — | -350.6%#5 | -1586.2%#1 | — | -90.4%#10 | — |
| PLUR | $15M#5 | — | — | 14.9x#3 | -24.0%#3 | -5.5%#6 | -2454.5%#3 | — | — | — | -69.2%#5 | — |
| DYAI | $15M#7 | — | — | 4.7x#2 | -11.6%#2 | -26.8%#8 | -232.8%#1 | — | — | — | -64.6%#4 | — |
| BCDA | $13M#8 | — | 4.9x#6 | — | -100.0%#5 | -3.5%#5 | — | -304.7%#4 | — | — | -32.6%#2 | — |
| BCLI | $13M#9 | — | — | — | — | 11.3%#3 | — | — | — | — | — | — |
| PASG | $12M#10 | — | 2.6x#5 | — | — | 29.7%#1 | — | -1021.6%#6 | — | — | -48.7%#3 | — |
| INTS | $11M#11 | — | 1.2x#3 | — | — | 28.7%#2 | — | -126.0%#2 | — | — | -89.9%#9 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice